Innovative Drug Discovery Approaches

Tuesday, October 29th, 13:30-17:30

BioInnovation Institute Fonden (Ole Maaløes Vej 3, DK 2200 Copenhagen N, Denmark)

Overview

Drug discovery is a critical phase in the pharmaceutical industry, where the identification, validation, and development of novel therapeutic agents begin. As the transformation of the global pharmaceutical landscape continues to accelerate, it is clear that specialized knowledge, technical expertise, resources, and adaptable processes are increasingly necessary. 

At the forefront of drug discovery, success relies on the close collaboration between pivotal technologies and experts in discovery pharmacology, screening, medicinal chemistry, DMPK/toxicology, and digital solutions. 

In this event, NUVISAN experts will share their experiences in early drug discovery research, highlighting key principles, challenges, and innovative approaches that drive this vital phase of drug discovery.

Registration

Agenda

13:30 – 14:00
Registration & Coffee

 

14:00 – 14:10
Welcome Reception & Introduction

Dr. Krzysztof Brzezinka, Business Development Manager

 

14:10 – 14:40
Nuvisan degrader capabilities

Dr. Duy Nguyen, Principal Scientist, Life Science Chemistry

 

14:40 – 15:10
Brake the driver: a journey into KRAS inhibition via SOS1, fragment screening, and HTS

Dr. Benjamin Bader, Head of Screening

 

15:10 – 15:30
Coffee Break

 

15:30 – 16:00
Guest Speaker (TBC)

 

16:00 – 16:30
Targeting the Hippo pathway in cancer: Phenotyping screening, target, and lead optimization of novel small molecule inhibitors

Dr. Peter Staller, Director, Translational Research

 

16:30 – 17:30
Networking & Food

Speakers

Dr. Krzysztof Brzezinka

Business Development Manager

Visit LinkedIn Profile

Dr. Duy Nguyen

Principal Scientist, Life Science Chemistry

Visit LinkedIn Profile

Dr. Benjamin Bader

Head of Screening

Visit LinkedIn Profile

Peter Staller

Dr. Peter Staller

Director, Translational Research

Visit LinkedIn Profile